from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2501c/accA1

LFCtreatmentdescriptionclass of inhibitor

-0.422

Amikacinug/mL Amikacintranslation

-1.052

Cap5-10ug/mL Capreomycintranslation

-1.518

Rox10-50 ug/mL Roxithromycintranslation

-0.808

SM2-5 ug/mL Streptomycintranslation

-1.280

Tet5-10 ug/mL Tetracyclinetranslation

-0.046

Rif0.2-5ug/mL Rifampicintranscription

-0.548

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.660

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.944

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.238

CPZ10-50 ug/mL Chlorpromazinerespiration

0.310

Clofazimine10-13 ug/mL Clofaziminerespiration

0.064

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

5.613

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.039

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.161

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.057

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.351

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.148

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.429

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.595

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.977

KCN5-20 ug/mL Potassium cyaniderespiration

-0.719

NaN30.2-2 mM Sodium aziderespiration

0.935

Nigericin50 uM Nigericinrespiration

1.122

TRC10-150 ug/mL Triclosanrespiration

1.941

TRZ10-25 ug/mL Thioridazinerespiration

0.607

Valinomycin0.5-10 uM Valinomycinrespiration

-1.120

ZnSO42 mM ZnSO4respiration

-0.564

menadione6-10 ug/mL Menadionerespiration

-0.060

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.376

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.041

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.427

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.361

NRP_1Non-replicating persistence stage 1dosRassociated

-0.710

Amp0.2mg/mL AmpicillincellWall

-0.304

Cephalexin20-100 ug/mL CephalexincellWall

-0.396

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.387

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.354

EMB10-20 ug/mL EthambutolcellWall

-0.845

Eta12-40 ug/mL EthionamidecellWall

-1.116

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.246

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.280

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.148

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.273

BZA0.12 mg/mL BenzamidearomaticAmides

-0.308

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.633

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.031

H2O24 mM hydrogen peroxideDNAdamaging

-0.422

Levo10 ug/mL LevofloxacinDNAdamaging

-0.355

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.827

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.467

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.194

UVUV-irradiationDNAdamaging

-0.276

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.085

Antimycin12.5-50 ug/mL Antimycin A?

-0.138

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.080

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.100

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.308

PA8240.2-2 ug/mL PA-824?

0.334

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.000

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.074

Verapamil50 uM Verapamil?

-0.378

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.099

methoxatin10-20 ug/mL Methoxatin?